“…This may also exclude the possibility that an increase in endogenous ACTH stimulates GH release, though Zahnd et al(1969) (Berson and Yalow, 1968) or longer (Berson and Yalow, 1968;Liddle et al, 1962;Strott et al, 1969;Jubiz et al, 1970a, and b) to stimulate the release of ACTH by a negative feedback mechanism. Therefore, the of metyrapone may not be caused by the negative feedback mechanism.…”
“…This may also exclude the possibility that an increase in endogenous ACTH stimulates GH release, though Zahnd et al(1969) (Berson and Yalow, 1968) or longer (Berson and Yalow, 1968;Liddle et al, 1962;Strott et al, 1969;Jubiz et al, 1970a, and b) to stimulate the release of ACTH by a negative feedback mechanism. Therefore, the of metyrapone may not be caused by the negative feedback mechanism.…”
“…For this reason metyrapone was initially considered to be ineffective for CD. Therefore, it was primarily used as a test for pituitary-adrenal reserve and the differential diagnosis of ACTH-dependent CS (48,49,50). Later studies in 18 patients with CS treated with a combination of metyrapone and aminoglutethimide, an antiepileptic and steroidogenesis enzyme inhibitor, indicated that metyrapone may be effective in improving clinical and biochemical features of CS (51).…”
Steroidogenesis enzyme inhibitors are the mainstay of medical therapy in Cushing's syndrome (CS). Ketoconazole (KTZ) and metyrapone are the most commonly used agents. Although there is considerable experience of their use in individual specialist centres, these drugs have not been rigorously tested in prospective clinical trials. Clinicians face uncertainties and concerns with respect to the safety profile of these agents, and best means to monitor effect. We review steroidogenesis inhibitors in the management of CS, including older agents (KTZ, metyrapone, etomidate and mitotane) and those currently under development (LCI699, non-racemic KTZ), and offer a practical approach for their use in clinical practice.
“…With a simple, accurate and highly reproducible method, relative specificity for quantitation of plasma S in post-metyrapone samples of plasma was proved by comparison of results obtained before and after chromatographic isolation of S. This high degree of specificity was accomplished by combining a CPB radioassay with a simple solvent extraction procedure which removes from the final extract large quantities of corticosteroids both more and less polar than S. Other extraction procedures that have been reported have the disadvantage that the recovery of S is lower, and other steroids that are found in plasma and would be assayed are extracted (1,6).…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.